
    
      -  Participants will be randomized into one of two study groups. The first group will
           receive Androgen Deprivation Therapy (ADT) plus bevacizumab. The second group will
           receive ADT alone.

        -  For the Androgen Deprivation therapy either (treating physician discretion)leuprolide or
           goserelin acetate (given as injections) every 3 months for a total of 6 months.
           Bicalutamide will also be taken orally daily for a total of 6 months.

        -  Bevacizumab will be given intravenously every three weeks for a total of 8 infusions
           over 6 months.

        -  Participants will be evaluated every 7-9 weeks with vitals, physical exam, PS,
           laboratories including PSA and testosterone.
    
  